{"id":211137,"date":"2017-08-11T17:45:55","date_gmt":"2017-08-11T21:45:55","guid":{"rendered":"http:\/\/www.euvolution.com\/prometheism-transhumanism-posthumanism\/mou-signed-to-commercialise-gene-therapy-in-india-odisha-sun-times\/"},"modified":"2017-08-11T17:45:55","modified_gmt":"2017-08-11T21:45:55","slug":"mou-signed-to-commercialise-gene-therapy-in-india-odisha-sun-times","status":"publish","type":"post","link":"https:\/\/www.euvolution.com\/prometheism-transhumanism-posthumanism\/transhuman-news-blog\/gene-medicine\/mou-signed-to-commercialise-gene-therapy-in-india-odisha-sun-times\/","title":{"rendered":"MoU signed to commercialise gene therapy in India &#8211; Odisha Sun Times"},"content":{"rendered":"<p><p>    New Delhi: In a bid to advance research and commercialise    regenerative medicine and gene therapy in India, the    Association of Biotechnology Led Enterprise (ABLE)  a    consortium of biotechnology companies  on Friday signed a    Memorandum of Understanding (MoU) with a Japan-based trade    association.  <\/p>\n<p>    The collaboration between ABLE and Forum for Innovative    Regenerative Medicine (FIRM) will focus on advancing the    individual and common missions by sharing information including    technology, policy and laws partnerships and opportunities such    as co-sponsoring meetings and other cooperation based on common    concern.  <\/p>\n<p>    It will also help advance and promote commercialisation of life    saving products in regenerative medicine within India, Japan    and other countries.  <\/p>\n<p>    We are proud to be a partner in this revolutionary research    and industry collaborations. The partnership is a step forward    to enhance the learning and training on cell and gene treatment    leading to enhancement of the cell and gene therapies which    help to address major unmet medical needs in India, P.    Manohar, Head (Committee for regenerative medicine group) at    ABLE, said in a statement on Friday.  <\/p>\n<p>    Our association with ABLE is an opportunity to work towards    the advancement of the field (of regenerative medicine and cell    and gene therapies) and tap on the potential to transform human    healthcare. Through the partnership, we can share learnings and    insights to contribute towards curing major human illness,    added Yuzo Toda, Chairman at FIRM. (IANS)  <\/p>\n<p><!-- Auto Generated --><\/p>\n<p>See the original post:<br \/>\n<a target=\"_blank\" href=\"http:\/\/odishasuntimes.com\/2017\/08\/11\/mou-signed-to-commercialise-gene-therapy-in-india\/\" title=\"MoU signed to commercialise gene therapy in India - Odisha Sun Times\">MoU signed to commercialise gene therapy in India - Odisha Sun Times<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p> New Delhi: In a bid to advance research and commercialise regenerative medicine and gene therapy in India, the Association of Biotechnology Led Enterprise (ABLE) a consortium of biotechnology companies on Friday signed a Memorandum of Understanding (MoU) with a Japan-based trade association. The collaboration between ABLE and Forum for Innovative Regenerative Medicine (FIRM) will focus on advancing the individual and common missions by sharing information including technology, policy and laws partnerships and opportunities such as co-sponsoring meetings and other cooperation based on common concern. It will also help advance and promote commercialisation of life saving products in regenerative medicine within India, Japan and other countries.  <a href=\"https:\/\/www.euvolution.com\/prometheism-transhumanism-posthumanism\/transhuman-news-blog\/gene-medicine\/mou-signed-to-commercialise-gene-therapy-in-india-odisha-sun-times\/\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[21],"tags":[],"class_list":["post-211137","post","type-post","status-publish","format-standard","hentry","category-gene-medicine"],"_links":{"self":[{"href":"https:\/\/www.euvolution.com\/prometheism-transhumanism-posthumanism\/wp-json\/wp\/v2\/posts\/211137"}],"collection":[{"href":"https:\/\/www.euvolution.com\/prometheism-transhumanism-posthumanism\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.euvolution.com\/prometheism-transhumanism-posthumanism\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/prometheism-transhumanism-posthumanism\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/prometheism-transhumanism-posthumanism\/wp-json\/wp\/v2\/comments?post=211137"}],"version-history":[{"count":0,"href":"https:\/\/www.euvolution.com\/prometheism-transhumanism-posthumanism\/wp-json\/wp\/v2\/posts\/211137\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.euvolution.com\/prometheism-transhumanism-posthumanism\/wp-json\/wp\/v2\/media?parent=211137"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.euvolution.com\/prometheism-transhumanism-posthumanism\/wp-json\/wp\/v2\/categories?post=211137"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.euvolution.com\/prometheism-transhumanism-posthumanism\/wp-json\/wp\/v2\/tags?post=211137"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}